{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:10:48Z","timestamp":1790367048728,"version":"4.1.0"},"reference-count":43,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antibiotic resistance is an individual and public health problem; multidrug-resistant infections could cause an estimated 10 million deaths worldwide by 2050. Unnecessary use of antimicrobials is the most important cause of resistance generation in the community, and an estimated 80% of antimicrobials are prescribed in primary health care, frequently for urinary tract infections (UTIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This paper presents the protocol for the first phase of the Urinary Tract Infections in Catalonia (Infeccions del tracte urinari a Catalunya) project. We aim to examine the epidemiology of the different types of UTIs in Catalonia (an autonomous community in Spain) and their diagnostic and therapeutic management by health professionals. Furthermore, we aim to evaluate the correlation between types and total consumption of antibiotics for recurrent UTIs in 2 cohorts of women with the presence and severity of infectious complications of urological origin, especially pyelonephritis and sepsis, and 2 potentially serious infections: pneumonia and COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study is a population-based observational cohort study including adults with a diagnosis of UTI registered in the Information System for the Development of Research in Primary Care (in Catalan: Sistema d\u2019informaci\u00f3 per al desenvolupament de la investigaci\u00f3 en atenci\u00f3 prim\u00e0ria), the Minimum Basic Data Sets of Hospital Discharges and Emergency Departments (in Catalan: Conjunt m\u00ednim b\u00e0sic de dades a l\u2019hospitalitzaci\u00f3 d'aguts i d\u2019atenci\u00f3 urgent), and data from the Hospital Dispensing Medicines Register (in Catalan: Medicaci\u00f3 hospital\u00e0ria de dispensaci\u00f3 ambulat\u00f2ria) of Catalonia from the period between 2012 and 2021. We will evaluate the variables obtained from the databases to analyze the proportion of different types of UTIs, the percentage of adequate antibiotic treatments prescribed or received for recurrent UTIs according to the national guidelines, and the proportion of UTIs with complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We expect to describe the epidemiology of UTIs in Catalonia from 2012 to 2021, as well as describe the diagnostic and therapeutic management of UTIs by health professionals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We expect to find a high percentage of UTI cases with inadequate management according to the national guidelines, considering that on many occasions UTIs are treated with second- or third-line antibiotic therapies with a preference for the longest regimens. Furthermore, the use of antibiotic suppressive therapies, or prophylaxis, in recurrent UTIs will likely be highly variable. Moreover, we aim to determine whether women with recurrent UTIs treated with antibiotic suppressive therapies have a higher incidence and severity of potentially serious future infections, with special attention to acute pyelonephritis, urosepsis, COVID-19, and pneumonia, compared to women who receive antibiotic treatment after they present with a UTI. This is an observational study of data from administrative databases that will not allow causality analysis. The limitations of the study will be handled according to the appropriate statistical methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>European Union Electronic Register of Post-Authorisation Studies EUPAS49724; https:\/\/www.encepp.eu\/encepp\/viewResource.htm?id=49725<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>International Registered Report Identifier (IRRID)<\/jats:title>\n                    <jats:p>DERR1-10.2196\/44244<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/44244","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:35:02Z","timestamp":1671518102000},"page":"e44244","source":"Crossref","is-referenced-by-count":9,"title":["Diagnostic and Therapeutic Management of Urinary Tract Infections in Catalonia, Spain: Protocol for an Observational Cohort Study"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1307-0943","authenticated-orcid":false,"given":"Ana","family":"Moragas Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-8864","authenticated-orcid":false,"given":"Silvia","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6644-717X","authenticated-orcid":false,"given":"Carl","family":"Llor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8630-152X","authenticated-orcid":false,"given":"Dan","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-6466","authenticated-orcid":false,"given":"Ana","family":"Garc\u00eda-Sangen\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-5056","authenticated-orcid":false,"given":"M\u00f2nica","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-3971","authenticated-orcid":false,"given":"Ramon","family":"Monf\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-9233","authenticated-orcid":false,"given":"Maria","family":"Giner-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"ref1","unstructured":"Antimicrobial resistance: tackling a crisis for the health and wealth of nationsReview on Antimicrobial Resistance20142022-12-21https:\/\/amr-review.org\/sites\/default\/files\/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"ref3","unstructured":"Antibiotic resistanceWorld Health Organization2022-11-05https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l780"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000228"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2560-1"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3785-x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2009.03.014"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(02)01054-9"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp030027"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l525"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy198"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003336"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2016.11.005"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2010.02.042"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-4-13"},{"key":"ref17","unstructured":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2020European Centre for Disease Prevention and Control2022-12-13https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-eueea-ears-net-annual-epidemiological-report-2020"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01317-17"},{"key":"ref19","unstructured":"Vigil\u00e0ncia de les infeccions relacionades amb l\u2019atenci\u00f3 sanit\u00e0ria a Catalunya (VINCat) - 2020Generalitat de Catalunya2022-12-13http:\/\/hdl.handle.net\/11351\/8277"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix233"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200868090-00002"},{"key":"ref22","year":"2017","journal-title":"Manual de enfermedades infecciosas en Atenci\u00f3n Primaria.  4a ed"},{"key":"ref23","unstructured":"Gu\u00eda de Terap\u00e9utica Antimicrobiana del \u00c1rea AljarafeJunta de Andaluc\u00eda20182022-10-28http:\/\/www.juntadeandalucia.es\/servicioandaluzdesalud\/guiaterapeuticaaljarafe\/guiaTerapeuticaAljarafe\/"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000620"},{"issue":"5","key":"ref25","first-page":"372","volume":"30","author":"Llor, C","year":"2017","journal-title":"Rev Esp Quimioter"},{"key":"ref26","unstructured":"GuptaKReccurrent simple cystitis in womenUpToDate2022-12-14https:\/\/www.uptodate.com\/contents\/recurrent-simple-cystitis-in-women"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10111364"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2017.1246055"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0212-6567(00)78703-8"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.aprim.2014.02.005"},{"key":"ref31","unstructured":"Information System for the Development of Research in Primary CareSistema d\u2019Informaci\u00f3 per al Desenvolupament de la Investigaci\u00f3 en Atenci\u00f3 Prim\u00e0ria2022-12-19https:\/\/www.sidiap.org\/index.php\/en\/"},{"key":"ref32","unstructured":"International statistical classification of diseases and related health problems, 10th revision, Fifth edition, 2016World Health Organization2022-12-22https:\/\/apps.who.int\/iris\/handle\/10665\/246208"},{"key":"ref33","unstructured":"ATC\/DDD Index 2023World Health Organization2022-12-22https:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyac068"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2012.01.020"},{"key":"ref36","unstructured":"ENCePP Resources DatabaseEuropean Network of Centres for Pharmacoepidemiology and Pharmacovigilance2022-12-19https:\/\/www.encepp.eu\/encepp\/resourcesDatabase.jsp"},{"key":"ref37","unstructured":"Conjunt m\u00ednim b\u00e0sic de dades (CMBD)Servei Catal\u00e0 de la Salut2022-11-07https:\/\/catsalut.gencat.cat\/ca\/proveidors-professionals\/registres-catalegs\/registres\/cmbd\/"},{"key":"ref38","unstructured":"Criteris i condicions per a l'adequaci\u00f3 de la indicaci\u00f3 i condicions d'utilitzaci\u00f3 de medicaments d'acord amb els informes dels comit\u00e8s d'experts: registre i seguiment cl\u00ednic: verificaci\u00f3 i acreditaci\u00f3 de les condicions de provisi\u00f3 i finan\u00e7ament pel CatSalut (01\/2011)Generalitat de Catalunya2022-11-07http:\/\/hdl.handle.net\/11351\/1329"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2019.09.009"},{"key":"ref40","unstructured":"Gonzalez MoneoMJP\u00e9rez MartinATractament de les infeccions del tracte urinari a l'Atenci\u00f3 Prim\u00e0riaSocietat Catalana de Medicina Familiar i Comunit\u00e0ria20122022-12-19http:\/\/gestorweb.camfic.cat\/uploads\/ITEM_5927_ART_117.pdf"},{"key":"ref41","unstructured":"Urological InfectionsEuropean Association of Urology2022-12-19https:\/\/uroweb.org\/guidelines\/urological-infections"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532"},{"key":"ref43","unstructured":"The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in PharmacoepidemiologyEuropean Medicines Agency2022-11-14https:\/\/www.encepp.eu\/standards_and_guidances\/methodologicalGuide.shtml"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2023\/1\/e44244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:48:06Z","timestamp":1782841686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2023\/1\/e44244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":43,"URL":"https:\/\/doi.org\/10.2196\/44244","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.44244","asserted-by":"object"}]},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}